| 臺大學術典藏 |
2020-11-03T11:44:39Z |
Comparison of the 2017 Taiwan lipid guidelines and the Western lipid guidelines for high risk patients
|
Li Y.-H.;Yeh H.-I.;Jiann-Shing Jeng;Charng M.-J.; Li Y.-H.; Yeh H.-I.; JIANN-SHING JENG; Charng M.-J. |
| 臺大學術典藏 |
2020-11-03T11:08:10Z |
2017 Taiwan lipid guidelines for high risk patients
|
Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; SUNG-CHUN TANG; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Chien K.-L.; Wang C.-Y.; Charng M.-J.; Lin T.-H.; Jeng J.-S.; Li Y.-H.; Ueng K.-C.; Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Sung-Chun Tang;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients |
| 臺大學術典藏 |
2020-11-03T11:08:02Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Liu P.-Y.; Chao T.-H.; Wang C.-Y.; Chien K.-L.; Lin T.-H.; Charng M.-J.; Jeng J.-S.; Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Sung-Chun Tang;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Yeh H.-I.; Wu C.-C.; Yu T.-Y.; Chen J.-W.; SUNG-CHUN TANG; Lee C.-C.; Liou C.-W.; Chien S.-C.; Su C.-H. |
| 臺大學術典藏 |
2020-11-03T11:07:56Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
SUNG-CHUN TANG; Li Y.-H.; Yeh H.-I.; Huang Y.-H.; Chen P.-S.; Chien S.-C.; Chien S.-C.;Chen P.-S.;Huang Y.-H.;Sung-Chun Tang;Li Y.-H.;Yeh H.-I. |
| 臺大學術典藏 |
2020-11-03T11:07:53Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; SUNG-CHUN TANG; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.; Wang C.-Y.; Huang W.-C.; Chang W.-T.; Chen Z.-C.; Huang C.-W.; Chen P.-W.; Wu C.-K.; Huang C.-C.; Chang K.-C.; Wu C.-C.; Yeh H.-I.; Wang Y.-C.; Lin T.-H.; Chen J.-W.; Li Y.-H.; Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Wu C.-C.;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Sung-Chun Tang;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L. |
| 臺大學術典藏 |
2020-10-26T11:34:32Z |
The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care
|
Wu C.-K.; JYH-MING JIMMY JUANG; Chiang J.-Y.; Li Y.-H.; Tsai C.-T.; Chiang F.-T. |
| 臺大學術典藏 |
2020-09-30T08:49:30Z |
The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients
|
Lin G.-M.; Li Y.-H.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I. |
| 臺大學術典藏 |
2020-09-30T08:49:25Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L.; Shyu K.-G.; Chao T.-H.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chen J.-F.; Yeh H.-I.; Wang T.-D.; Lin T.-H.; Lin S.-Y.; Chiang C.-E. |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators; Ho L.-T.; Lin F.-J. |
| 臺大學術典藏 |
2020-09-30T08:49:14Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Yang Y.-C.; YEN-WEN WU; Hwang J.-J.; Lin J.-L.; Chan H.-L.; Tang S.-C.; Tsai L.-K.; Fu W.-R.; Chao A.-C.; Lee M.-Y.; Wang C.-Y.; Huang W.-C.; Chang W.-T.; Chen Z.-C.; Huang C.-W.; Chen P.-W.; Wu C.-K.; Huang C.-C.; Chang K.-C.; Yeh H.-I.; Wu C.-C.; Wang Y.-C.; Li Y.-H.; Chen J.-W.; Lin T.-H. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J.; Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I. |
| 臺大學術典藏 |
2020-09-30T02:30:08Z |
The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine – A phase I randomized clinical trial
|
Cheng A.;Hsieh S.-M.;Sung-Ching Pan;Li Y.-H.;Hsieh E.-F.;Lee H.-C.;Lin T.-W.;Lai K.-L.;Chen C.;Shi-Chung Chang S.;Chang S.-C.; Cheng A.; Hsieh S.-M.; SUNG-CHING PAN; Li Y.-H.; Hsieh E.-F.; Lee H.-C.; Lin T.-W.; Lai K.-L.; Shi-Chung Chang S.; Chang S.-C.; Chen C. |
| 臺大學術典藏 |
2020-06-01T09:06:40Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Chih-Yuan Wang;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; CHIH-YUAN WANG; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Yeh H.-I.; Wu C.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W. |
| 臺大學術典藏 |
2020-05-04T08:09:17Z |
Performance analysis of type-II hybrid ARQ systems
|
Kao, Y.-H.; Li, Y.-H.; Lin, W.-A.; Hu, H.-C.; Yeh, P.-C.; YEN-HUAN LI |
| 臺大學術典藏 |
2020-05-04T08:09:17Z |
Adaptive precoder selection for multicast/broadcast services in MIMO-OFDMA systems
|
YEN-HUAN LI; Yeh, P.-C.; Li, Y.-H.; Hu, H.-C.; Hu, H.-C.;Li, Y.-H.;Yeh, P.-C. |
| 臺大學術典藏 |
2020-05-04T08:09:16Z |
Convergence of the Exponentiated Gradient Method with Armijo Line Search
|
Li, Y.-H.;Cevher, V.; Li, Y.-H.; Cevher, V.; YEN-HUAN LI |
| 臺大學術典藏 |
2020-05-04T08:09:16Z |
MIMO-OFDM PHY Integrated (MOPI) scheme for confidential wireless transmission
|
Cheng, J.-P.;Li, Y.-H.;Yeh, P.-C.;Cheng, C.-M.; Cheng, J.-P.; Li, Y.-H.; Yeh, P.-C.; Cheng, C.-M.; YEN-HUAN LI |
| 臺大學術典藏 |
2020-03-31T08:25:19Z |
Induced voltage measurements on a YBa 2Cu 3O 7-δ superconducting thin film due to a pair of rotating magnets
|
Lin, J. G.; Wang, L. M.; Chan, W. C.; Chiang, C. H.; Li, Y. H. |
| 臺大學術典藏 |
2020-03-24T03:47:55Z |
The Asia-Pacific Society of Cardiology (APSC) expert committee consensus recommendations for assessment of suspected acute coronary syndrome using high-sensitivity cardiac troponin T in the emergency department
|
Chew D.P.;Youn J.-C.;Phrommintikul A.;CHIEN-CHANG LEE;Devasia T.;Chu F.-Y.;Than M.;Lukito A.A.;Lim S.H.;Li Y.-H.;Dung H.T.;Cheng F.;Aw T.C.;Shiozaki M.;Kasim S.;Giannitsis E.;AbdelWareth L.;Inoue K.;Jack Tan W.C.; Jack Tan W.C.; Inoue K.; AbdelWareth L.; Giannitsis E.; Kasim S.; Shiozaki M.; Aw T.C.; Cheng F.; Dung H.T.; Li Y.-H.; Lim S.H.; Lukito A.A.; Than M.; Chu F.-Y.; Devasia T.; CHIEN-CHANG LEE; Phrommintikul A.; Youn J.-C.; Chew D.P. |
| 臺大學術典藏 |
2020-03-23T07:19:32Z |
Development and characterization of a specific anti-caveolin-1 antibody for Caveolin-1 functional study in human, goat and mouse
|
Ke M.-W.; Jiang Y.-N.; Li Y.-H.; Tseng T.-Y.; Kung M.-S.; CHIUN-SHENG HUANG; Cheng W.T.-K.; Hsu J.-T.; Ju Y.-T. |
| 臺大學術典藏 |
2020-03-05T06:05:32Z |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
|
LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H. |
| 臺大學術典藏 |
2020-03-05T06:05:29Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
